Drug name - Vimovo

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6926907 HORIZON Pharmaceutical compositions for the coordinated delivery of NSAIDs Feb, 2023

(4 months from now)

US9393208 HORIZON Method for delivering a pharmaceutical composition to patient in need thereof Sep, 2029

(6 years from now)

US9220698 HORIZON Method for delivering a pharmaceutical composition to patient in need thereof Mar, 2031

(8 years from now)

US8945621 HORIZON Method for treating a patient at risk for developing an NSAID-associated ulcer Oct, 2031

(9 years from now)

Drugs and Companies using ESOMEPRAZOLE MAGNESIUM; NAPROXEN ingredient

Treatment: Relief of signs and symptoms of arthritis and risk-reduction of nsaid-associated gastric ulcer; Risk-reduction of nsaid-associated gastric ulcer in patients requiring nsaid treatment; Risk-reduction of nsaid-associated gastric ulcers in patients also taking low dose aspirin

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 20MG BASE;375MG TABLET, DELAYED RELEASE;ORAL Prescription
EQ 20MG BASE;500MG TABLET, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.